UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1014: Dosimetric evaluation of accelerated partial breast irradiation using VMAT technique

Radiotherapy and oncology, 2024-05, Vol.194, p.S3529-S3531

2024

Volltextzugriff (PDF)

Increasing parvovirus filter throughput of monoclonal antibodies using ion exchange membrane adsorptive pre-filtration

Biotechnology and bioengineering, 2010-07, Vol.106 (4), p.627-637

2010

Volltextzugriff (PDF)

Reproductive resilience but not root architecture underpins yield improvement under drought in maize

Journal of experimental botany, 2021-07, Vol.72 (14), p.5235-5245

2021

Volltextzugriff (PDF)

Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab

Journal of clinical oncology, 2015-06, Vol.33 (18), p.2013-2020

2015

Volltextzugriff (PDF)

Penetrating injuries to the duodenum: An analysis of 879 patients from the National Trauma Data Bank, 2010 to 2014

The journal of trauma and acute care surgery, 2017-11, Vol.83 (5), p.810-817

2017

Volltextzugriff (PDF)

A subgroup analysis of penetrating injuries to the pancreas: 777 patients from the National Trauma Data Bank, 2010-2014

The Journal of surgical research, 2018-05, Vol.225, p.131-141

2018

Volltextzugriff (PDF)

GSOR4 Presentation Time: 9:15 AM: Predicting the Benefit of Hybrid Intracavitary + Interstitial Needle Applicators in Patients with Locally Advanced Cervical Cancer

Brachytherapy, 2022-11, Vol.21 (6), p.S51-S52

2022

Volltextzugriff (PDF)

GSOR4 Presentation Time: 9:15 AM

Brachytherapy, 2022-11, Vol.21 (6), p.S51-S52

2022

Volltextzugriff (PDF)

Assessment of Surface Preparation Methods for Mercury (Hg) Probe Schottky Capacitance-Voltage (MCV) on Epitaxial Silicon

ECS journal of solid state science and technology, 2021-07, Vol.10 (7), p.74006

2021

Volltextzugriff (PDF)

Using the Wilder Collaboration Factors Inventory to Assess SNAP‐Ed Coalitions in Arizona: Results from Four Counties

The FASEB journal, 2017-04, Vol.31 (S1)

2017

Volltextzugriff (PDF)

The Tiger Country Series: Penetrating Pancreaticoduodenal Injuries, Analysis of 145 Patients from the National Trauma Data Bank (NTDB) 2010 to 2014

Journal of the American College of Surgeons, 2017-10, Vol.225 (4), p.e189-e189

2017

Volltextzugriff (PDF)

Catalysis-in-a-Box: Robotic Screening of Catalytic Materials in the Time of COVID-19 and Beyond

Matter, 2020-09, Vol.3 (3), p.805-823

2020

Volltextzugriff (PDF)

Catalysis-in-a-Box: Robotic Screening of Catalytic Materials in the Time of COVID-19 and Beyond

Matter, 2020-09, Vol.3 (3)

2020

Volltextzugriff (PDF)

Catalysis-in-a-Box: Robotic Screening of Catalytic Materials in the Time of COVID-19 and Beyond

Matter, 2020-09, Vol.3 (3)

2020

Volltextzugriff (PDF)

Conducting Research With Communities of Color

Society & natural resources, 2000-07, Vol.13 (5), p.479-488

Leo Mcavoy, Patricia L. Winter, Corliss Wilson Outley, Dan Mcdonald, Deborah J. Chavez

2000

Volltextzugriff (PDF)

India Benefits from SMO Presence

Applied clinical trials, 2008-02, Vol.17 (2), p.66

McDonald, Dan

2008

Volltextzugriff (PDF)

India benefits from SMO Presence: contributions include GCP training and assistance for investigators

Applied clinical trials, 2008-02, Vol.17 (2), p.66

McDonald, Dan

2008

Volltextzugriff (PDF)

Clinical pharmacokinetics (PK) of BMS-936558, a fully human anti-PD-1 monoclonal antibody

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS2622-TPS2622

2012

Volltextzugriff (PDF)

A phase I dose escalation and cohort expansion study of lirilumab (anti-KIR; BMS-986015) in combination with nivolumab (anti-PD-1; BMS-936558, ONO-4538) in advanced solid tumors

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS3115-TPS3115

2014

Volltextzugriff (PDF)

Clinical activity and safety of anti-PD1 (BMS-936558, MDX-1106) in patients with advanced non-small-cell lung cancer (NSCLC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.7509-7509

2012

Volltextzugriff (PDF)

Clinical activity and safety of anti-PD-1 (BMS-936558, MDX-1106) in patients with previously treated metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4505-4505

2012

Volltextzugriff (PDF)

An exploratory study to investigate the immunomodulatory activity of BMS-936558 in patients with metastatic clear-cell renal cell carcinoma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS2613-TPS2613

2012

Volltextzugriff (PDF)

Clinical activity and safety of anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced melanoma (MEL)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.8507-8507

2012

Volltextzugriff (PDF)

A phase I dose-escalation and cohort expansion study of lirilumab (anti-KIR; BMS-986015) administered in combination with nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients (Pts) with advanced refractory solid tumors

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.TPS3110-TPS3110

2013

Volltextzugriff (PDF)

Anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced solid tumors: Clinical activity, safety, and a potential biomarker for response

Journal of clinical oncology, 2012-06, Vol.30 (18_suppl), p.CRA2509-CRA2509

2012

Volltextzugriff (PDF)

1 – 25 von 364

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(304)
Mit Volltextzugriff
(301)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(361)
Deutsch
(1)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

1014: Dosimetric evaluation of accelerated partial breast irradiation using VMAT technique

Increasing parvovirus filter throughput of monoclonal antibodies using ion exchange membrane adsorptive pre-filtration

Reproductive resilience but not root architecture underpins yield improvement under drought in maize

Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab

Penetrating injuries to the duodenum: An analysis of 879 patients from the National Trauma Data Bank, 2010 to 2014

A subgroup analysis of penetrating injuries to the pancreas: 777 patients from the National Trauma Data Bank, 2010-2014

GSOR4 Presentation Time: 9:15 AM: Predicting the Benefit of Hybrid Intracavitary + Interstitial Needle Applicators in Patients with Locally Advanced Cervical Cancer

GSOR4 Presentation Time: 9:15 AM

Assessment of Surface Preparation Methods for Mercury (Hg) Probe Schottky Capacitance-Voltage (MCV) on Epitaxial Silicon

Using the Wilder Collaboration Factors Inventory to Assess SNAP‐Ed Coalitions in Arizona: Results from Four Counties

The Tiger Country Series: Penetrating Pancreaticoduodenal Injuries, Analysis of 145 Patients from the National Trauma Data Bank (NTDB) 2010 to 2014

Catalysis-in-a-Box: Robotic Screening of Catalytic Materials in the Time of COVID-19 and Beyond

Catalysis-in-a-Box: Robotic Screening of Catalytic Materials in the Time of COVID-19 and Beyond

Catalysis-in-a-Box: Robotic Screening of Catalytic Materials in the Time of COVID-19 and Beyond

Conducting Research With Communities of Color

India Benefits from SMO Presence

India benefits from SMO Presence: contributions include GCP training and assistance for investigators

Clinical pharmacokinetics (PK) of BMS-936558, a fully human anti-PD-1 monoclonal antibody

A phase I dose escalation and cohort expansion study of lirilumab (anti-KIR; BMS-986015) in combination with nivolumab (anti-PD-1; BMS-936558, ONO-4538) in advanced solid tumors

Clinical activity and safety of anti-PD1 (BMS-936558, MDX-1106) in patients with advanced non-small-cell lung cancer (NSCLC)

Clinical activity and safety of anti-PD-1 (BMS-936558, MDX-1106) in patients with previously treated metastatic renal cell carcinoma (mRCC)

An exploratory study to investigate the immunomodulatory activity of BMS-936558 in patients with metastatic clear-cell renal cell carcinoma

Clinical activity and safety of anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced melanoma (MEL)

A phase I dose-escalation and cohort expansion study of lirilumab (anti-KIR; BMS-986015) administered in combination with nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients (Pts) with advanced refractory solid tumors

Anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced solid tumors: Clinical activity, safety, and a potential biomarker for response

Suchergebnisse filtern